Laos vs Sao Tome and Principe: Population requiring preventive chemotherapy for schistosomiasis
Laos
115,265
in 2024
Sao Tome and Principe
42,776
in 2024
Laos rank
48th
Sao Tome and Principe rank
51st
Population requiring preventive chemotherapy for schistosomiasis over time
- Laos
- Sao Tome and Principe
How they compare
Laos currently reports 115,265 against 42,776 in Sao Tome and Principe, a difference of 72,489.
That makes Laos's figure about 2.7 times Sao Tome and Principe's.
Across all 15 years both countries report, Laos has been ahead every year.
Laos ranks 48th and Sao Tome and Principe ranks 51st of 52 countries.
Laos has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Laos | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61,973 | 19,215 | 42,758 | Laos |
| 2020s | 114,847 | 41,213 | 73,635 | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Laos or Sao Tome and Principe?
- Laos, at 115,265 against 42,776 in Sao Tome and Principe as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Laos and Sao Tome and Principe?
- 72,489, with Laos ahead.
- How many years of comparable data are there for Laos and Sao Tome and Principe?
- 15 years are reported by both, from 2010 to 2024.
- How do Laos and Sao Tome and Principe rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Laos ranks 48th and Sao Tome and Principe ranks 51st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.